-
Mashup Score: 0Amazon to layoff more than 18K employees - 2 year(s) ago
Amazon (AMZN) is reducing its headcount by more than 17K employees, according to the Wall Street Journal.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
ViiV Healthcare has won regulatory support in EU for a new dispersible tablet formulation of its HIV drug Triumeq PD for children. Read the full story here.
Source: SeekingAlphaCategories: Infectious Disease, Latest HeadlinesTweet-
Triumeq PD for children https://t.co/5KoxTy7Qpx
-
-
Mashup Score: 0
Microsoft (MSFT), T-Mobile (TMUS) and Verizon (VZ) are among investment firm Oppenheimer’s top cloud and communications stocks for 2023 for a variety of reasons.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Microsoft, T-Mobile, Verizon among Oppenheimer's top cloud, telco stocks for 2023 | Seeking Alpha https://t.co/cootURhwDQ
-
-
Mashup Score: 0Teladoc: Death By A thousand Paper Cuts (NYSE:TDOC) - 2 year(s) ago
Teladoc achieves adjusted EBITDA profitability while its sales growth is slowing. See why I believe that TDOC stock is still expensive.
Source: SeekingAlphaCategories: Future of Medicine, Latest HeadlinesTweet-
Teladoc: Death By A thousand Paper Cuts. $TDOC #telemedicine #digitalhealth https://t.co/Y1J9GaeQDN
-
-
Mashup Score: 0
The FDA announced Friday that a panel of experts would meet in January to discuss how to revise the currently available COVID-19 vaccines and boosters. Read the full story here.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
FDA sets January meeting to consider further updates to COVID shots https://t.co/1cs0pVcocW
-
-
Mashup Score: 0VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio (NASDAQ:VBIV) - 2 year(s) ago
Health Canada has approved VBI Vaccines (VBIV) hepatitis B vaccine PreHevbrio.The approval is the fourth for the triple-antigen shot.
Source: SeekingAlphaCategories: Infectious Disease, Latest HeadlinesTweet-
“Results showed that those on PreHevbrio had statistically significant higher rates of seroprotection compared to the Engerix-B” https://t.co/yT2qOyqRvd
-
-
Mashup Score: 7Mirati non-small cell lung cancer treatment adagrasib gains FDA approval - Bloomberg - 2 year(s) ago
The US FDA has approved Mirati Therapeutics (MRTX) Krazati (adagrasib) a second-line treatment for non-small cell lung cancer, Bloomberg reported.
Source: SeekingAlphaCategories: Hem/Oncs, Latest HeadlinesTweet-
📢$MRTX - Mirati non-small cell lung cancer treatment adagrasib gains FDA approval - Bloomberg @KRASKickers @TerriConneran @OncoAlert https://t.co/6PVYDD6XNn
-
-
Mashup Score: 0
A new study indicates updated mRNA-based COVID boosters from Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) generated a weaker response to new COVID subvariants. Read the full story here.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Omicron boosters are weaker against emerging COVID variants – study https://t.co/VYgq8wUgcE
-
-
Mashup Score: 1
In vitro diagnostics company Accelerate Diagnostics (AXDX) fell ~15% after reporting a miss in Q3 revenue and lowering FY22 guidance.
Source: SeekingAlphaCategories: Infectious Disease, Latest HeadlinesTweet-
"Hospitals are slowly regaining their footing and seeing their patient mix improve. This has contributed to a full return to pre-pandemic levels of bloodstream infection testing and more predictable customer consumable purchases” https://t.co/NOywIti186
-
-
Mashup Score: 0BrainStorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2019 Results - Earnings Call Transcript - 2 year(s) ago
BrainStorm Cell Therapeutics Inc. (NASDAQ:NASDAQ:BCLI) Q4 2019 Results Earnings Conference Call February 18, 2020, 08:00 AM ET Company Participants Sean Leous – ICR Westwicke Chaim Lebovits…
Source: SeekingAlphaCategories: Latest Headlines, Rare DiseaseTweet-
An interesting trip down memory lane from Feb 2020... https://t.co/TokkkV20hi
-
Amazon to layoff more than 18K employees https://t.co/DYOGCuiLIE #CES2023